Turkish Journal of Nephrology
Original Article

Evaluation of Morbidity and Patient and Graft Survival in Kidney Transplant Recipients: Experience of Dokuz Eylul University Hospital

1.

Menemen Devlet Hastanesi, Nefroloji Kliniği, İzmir, Türkiye

2.

Dokuz Eylül Üniversitesi Tıp Fakültesi, Nefroloji Bilim Dalı, İzmir, Türkiye

3.

Dokuz Eylül Üniversitesi Tıp Fakültesi, Genel Cerrahi Anabilim Dalı, İzmir, Türkiye

4.

Dokuz Eylül Üniversitesi Tıp Fakültesi, Patoloji Anabilim Dalı, İzmir, Türkiye

Turkish J Nephrol 2017; 26: 41-47
DOI: 10.5262/tndt.2017.1001.07
Read: 1432 Downloads: 845 Published: 30 January 2019

OBJECTIVE: The aim of the study was to retrospectively investigate and evaluate clinical findings and influencing factors related with graft and patient survival in kidney transplant recipients at Dokuz Eylul University Hospital.

MATERIAL and METHODS: 286 kidney transplant recipients were included in the study. All patients were transplanted between the dates of January 1993 and January 2014 at Dokuz Eylul University Hospital. The demographic features, clinical and laboratory findings, donor types, HLA matchings, donor properties, renal failure etiology, dialysis modalities, post transplant complications, rejection attacks, and graft loss and death etiology were retrospectively investigated.

RESULTS: The mean post transplant follow-up period of 286 patients (166 male, 120 female, mean age 37±12.09 years) was 93.55±54.45 months. 147 had living donors and 139 had deceased donor transplantation. Although graft and patient survival rates were higher in the living donor group than the deceased donor group, no statistically significant difference was found between the two groups.

CONCLUSION: The overall graft and patient survival rates in our study were compatible with the literature. Morbidity and mortality related with transplantation continues for many years in kidney transplant recipients due to the suppression of the immune system with drugs.  

Files
EISSN 2667-4440